Senores PharmaceuticalsNSE:SENORES -0.44%29 Days Payable is 323.44 as of Mar. 2026, which is 48% above its 10-year median of 218.96. GuruFocus rates NSE:SENORES with a GF Score™ of 29/100. The stock has 7 warning signs investors should review. Among 922 Drug Manufacturers companies, Senores Pharmaceuticals ranks better than 85.57% on this metric.
The historical rank and industry rank for Senores Pharmaceuticals's Days Payable or its related term are showing as below:
NSE:SENORES'
s Days Payable Range Over the Past 10 Years
Min: 182.03 Med: 218.96 Max: 324.2
Current: 205.81
During the past 5 years, Senores Pharmaceuticals's highest Days Payable was 324.20. The lowest was 182.03. And the median was 218.96.
NSE:SENORES's Days Payable is ranked better than 85.57% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.61
vs NSE:SENORES: 205.81
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SENORES vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, Senores Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senores Pharmaceuticals Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Senores Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where Senores Pharmaceuticals's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Senores Pharmaceuticals's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Senores Pharmaceuticals (NSE:SENORES) has a Days Payable of 323.44 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Senores Pharmaceuticals and its competitors. This is 48% above median its historical median of 218.96. Over the past decade, Senores Pharmaceuticals' Days Payable has ranged from 182.03 to 324.20. According to the industry distribution chart, Senores Pharmaceuticals ranks #133 out of 922 companies in the Drug Manufacturers industry, placing it in the top 14.4%.
Is Senores Pharmaceuticals' Days Payable too high?
Senores Pharmaceuticals' current Days Payable of 323.44 is 48% above median its 10-year median of 218.96. Over the past 10 years, this metric has ranged from a low of 182.03 to a high of 324.20. The Drug Manufacturers industry median Days Payable is 90.61. Senores Pharmaceuticals' value of 323.44 is 257% above this industry median. Based on the distribution chart, Senores Pharmaceuticals ranks #133 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Senores Pharmaceuticals has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Senores Pharmaceuticals' Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Senores Pharmaceuticals ranks #133 out of 922 companies for Days Payable. This places Senores Pharmaceuticals in the top 14% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.61. Senores Pharmaceuticals' value of 323.44 is 257% above this benchmark. Historically, Senores Pharmaceuticals' own Days Payable has ranged from 182.03 to 324.20 over the past decade. While the company's 10-year median is 218.96 vs. the industry median of 90.61, Senores Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senores Pharmaceuticals's current Days Payable of 323.44 is 257% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Senores Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senores Pharmaceuticals's current Days Payable is 323.44, which is 48% above median its own 10-year median of 218.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senores Pharmaceuticals stock overvalued right now?
Senores Pharmaceuticals (NSE:SENORES) has a current Days Payable of 323.44. The current Days Payable is 323.44, which is 48% above median its 10-year median of 218.96 and 257% above the Drug Manufacturers industry median of 90.61. Senores Pharmaceuticals' overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Senores Pharmaceuticals (NSE:SENORES), the current Days Payable is 323.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Senores Pharmaceuticals Ltd is a research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of the USA, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Its strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing the company as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, It strategically identifies commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets.
29GF Score
Get the complete analysis for NSE:SENORES
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SENORES has been successfully added to your 
